Literature DB >> 23075866

A lecture on the genetics of primary sclerosing cholangitis.

Tom H Karlsen1.   

Abstract

As a result of international collaborations and application of genome-wide association studies (GWAS), a number of susceptibility genes for primary sclerosing cholangitis (PSC) have been detected over the recent years. The genetic architecture of PSC resembles prototypical HLA-associated autoimmune diseases almost as much as that of inflammatory bowel disease. All susceptibility loci reported have previously been detected in other phenotypes in accordance with a paradigm where risk loci detected by GWAS are likely to represent broad phenotypic features like inflammation rather than disease-specific affections. The risk loci have opened up for mechanistic studies in relevant model systems that are likely to enhance understanding of PSC pathogenesis. This review aims to summarize the status and thinking on genetics of PSC as drawn from present data and a series of recent review articles. A particular emphasis will be put on future opportunities related to the incorporation of metagenomic data in the analysis.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23075866     DOI: 10.1159/000341122

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  5 in total

Review 1.  Genetics in PSC: what do the "risk genes" teach us?

Authors:  Trine Folseraas; Evaggelia Liaskou; Carl A Anderson; Tom H Karlsen
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

2.  Tumour necrosis factor alpha (TNF-α) genetic polymorphisms and the risk of autoimmune liver disease: a meta-analysis.

Authors:  Shan Li; Xiamei Huang; Huizhi Zhong; Zhiping Chen; Qiliu Peng; Yan Deng; Xue Qin
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

3.  Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.

Authors:  Agnes Gwela; Priya Siddhanathi; Roger W Chapman; Simon Travis; Fiona Powrie; Carolina V Arancibia-Cárcamo; Alessandra Geremia
Journal:  J Crohns Colitis       Date:  2017-09-01       Impact factor: 9.071

4.  A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis.

Authors:  Yevgeniy Gindin; Chuhan Chung; Zhaoshi Jiang; Jing Zhu Zhou; Jun Xu; Andrew N Billin; Robert P Myers; Zachary Goodman; Abdolamir Landi; Michael Houghton; Richard M Green; Cynthia Levy; Kris V Kowdley; Christopher L Bowlus; Andrew J Muir; Michael Trauner
Journal:  Hepatology       Date:  2021-02-28       Impact factor: 17.425

5.  Overexpression of Cancer-Associated Stem Cell Gene OLFM4 in the Colonic Epithelium of Patients With Primary Sclerosing Cholangitis.

Authors:  Mastura Neyazi; Sraddha S Bharadwaj; Samuel Bullers; Zofia Varenyiova; Simon Travis; Carolina V Arancibia-Cárcamo; Fiona Powrie; Alessandra Geremia
Journal:  Inflamm Bowel Dis       Date:  2021-07-27       Impact factor: 5.325

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.